Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
09/26/2007 | CN101040941A Chinese medicine composition for treating skin disease |
09/26/2007 | CN101040935A Dropping pills agent for removing phlegm and relieving asthma and cough and the preparing method |
09/26/2007 | CN101040931A Chinese traditional medicine took orally for treating psoriasis |
09/26/2007 | CN101040927A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
09/26/2007 | CN101040926A Chinese traditional medicine compound took orally for treating cervical spondylosis |
09/26/2007 | CN101040925A Traditional Chinese medicine composition for curing hyperosteogeny for external application |
09/26/2007 | CN101040922A Chinese traditional medicine compound for treating gout |
09/26/2007 | CN101040921A Immunopotentiator of trepang compound Chinese traditional medicine |
09/26/2007 | CN101040912A Chinese traditional medicine capsule preparation for resisting radiation and improving immunity and the method for preparing the same |
09/26/2007 | CN101040908A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
09/26/2007 | CN101040898A Diphtheritic powder |
09/26/2007 | CN101040876A Traditional Chinese medicine composition took orally for curing hyperosteogeny |
09/26/2007 | CN101040875A Physiology injection liquid of deep seawater |
09/26/2007 | CN101040632A Milk product with specific immunity of anti-enterobacter sakazakii and the preparing method thereof |
09/26/2007 | CN100339477C Methods and devices for tissure repair |
09/26/2007 | CN100339474C Novel bacillus and its separation method and application |
09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
09/26/2007 | CN100339375C Metabolites of ecteinascidin 743 |
09/26/2007 | CN100339130C 疫苗 Vaccine |
09/26/2007 | CN100339124C Guiyuan oral liquid and its preparing process |
09/26/2007 | CN100339117C Medicine for treating fatty liver |
09/26/2007 | CN100339113C Chinese medicine capsule for treating epilepsy |
09/26/2007 | CN100339112C Chinese medicine for treating hypertension emergency |
09/26/2007 | CN100339111C Medicine for treating coronary heart disease and its prepn |
09/26/2007 | CN100339102C Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation |
09/26/2007 | CN100339100C Alopecia areata treating medicine |
09/26/2007 | CN100339095C Cervical spondylosis treating Chinese medicine composition |
09/26/2007 | CN100339092C Chinese medicine composition for treating apoplexy and its prepn process and use |
09/26/2007 | CN100339091C Recipe and prepn. method of medicinal composition for treating coronary disease and heartstroke |
09/26/2007 | CN100339088C Medicine for treating child hernia and its preparation method |
09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
09/25/2007 | US7273698 Defects in periaxin associated with myelinopathies |
09/25/2007 | US7273694 Method and apparatus for reducing pathogens in a biological sample |
09/25/2007 | US7273626 Herbal preparation for management of cardiovascular and neurologic disorders |
09/25/2007 | US7273607 Comprises vitamins, minerals, amino acids, herbs, and essential oils; side effect reduction |
09/25/2007 | US7273605 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
09/25/2007 | US7273602 Immunotherapy for humans |
09/25/2007 | US7273466 Apparatus having a defoamer-coated surface and use of a defoamer-containing surface |
09/25/2007 | CA2318424C Use of odorants to alter vaginal blood flow, and article of manufacture therefor |
09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
09/25/2007 | CA2192442C Complementary adenoviral vector systems and cell lines |
09/20/2007 | WO2007106049A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
09/20/2007 | WO2007105945A2 Use of non-digestable sacharides for giving an infant the best start after birth |
09/20/2007 | WO2007105797A1 Novel human t cell population |
09/20/2007 | WO2007105744A1 Purkinje cell-tropic viral vector |
09/20/2007 | WO2007104581A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
09/20/2007 | WO2007104562A1 Dry powder compositions and systems for poultry vaccination |
09/20/2007 | WO2007104493A1 Use for vasoactive intestinal peptide (vip) and the isolated cells stimulated by said peptide |
09/20/2007 | WO2007070301A9 Vascular graft sterilization and decellularization |
09/20/2007 | WO2007059031A3 Methods and compositions for raising levels and release of gamma aminobutyric acid |
09/20/2007 | WO2007022082A3 Vector delivery-based microbicides |
09/20/2007 | WO2005092068A3 Novel method of neuroprotection by pharmacological inhibition of amp-activated protein kinase |
09/20/2007 | US20070219526 Restenosis Therapy Using Mesenchymal Stem Cells |
09/20/2007 | US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences |
09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
09/20/2007 | US20070219126 Class of bioactive glycoprotein |
09/20/2007 | US20070218549 Compositions comprising conditioned cell culture media and uses thereof |
09/20/2007 | US20070218143 Topical preparation |
09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
09/20/2007 | US20070218059 Cell Surface Marker |
09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
09/20/2007 | US20070218040 Providing segment of small intestinal submucosa, isolating and culturing multipotent cell type which is seeded and allowed to differentiate |
09/20/2007 | US20070218039 Conjunctival tissue system |
09/20/2007 | US20070218038 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
09/20/2007 | US20070218037 Therapeutic agent for fibromyalgia |
09/20/2007 | US20070218036 Method For The Prevention Of Infection With Nodavirus And Method For The Treatment Thereof |
09/20/2007 | US20070218033 Composition and method of treating hepatitis C |
09/20/2007 | DE19882435B4 Verfahren zur Hemmung von Krebszellwachstum mit einem pRb2/p130 exprimierenden Vektor Methods of inhibiting cancer cell growth with a pRb2 / p130 expressing vector |
09/20/2007 | DE102006011534A1 Plasma-Lyophilisat Plasma lyophilisate |
09/20/2007 | CA2646240A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
09/20/2007 | CA2645472A1 Use of non-digestable saccharides for giving an infant the best start after birth |
09/20/2007 | CA2643580A1 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance |
09/20/2007 | CA2638746A1 Recombinant mononegaviral virus vectors |
09/19/2007 | EP1835053A1 Synthetic nacre, method of manufacture and apparatus therefor |
09/19/2007 | EP1835031A1 Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans |
09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
09/19/2007 | EP1835023A1 Human corneal endothelial cell-derived precursor cell and cell aggregate, process for producing the same, and method for transplanting precursor cell and cell aggregate |
09/19/2007 | EP1835021A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
09/19/2007 | EP1834651A1 Compositions and methods for veterinary vaccination |
09/19/2007 | EP1834650A1 Cancer vaccine preparation |
09/19/2007 | EP1833964A1 Regulation of metalloprotease cleavage of cell surface proteins |
09/19/2007 | EP1833963A1 Composition for treating baldness with stem cell derived from umbilical cord blood |
09/19/2007 | EP1833829A2 Benzamide substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
09/19/2007 | EP1833497A1 Bacteriophage compositions |
09/19/2007 | EP1833496A2 Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
09/19/2007 | EP1833495A1 Dermatologic use of milk proteins |
09/19/2007 | EP1833494A2 Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
09/19/2007 | EP1833306A1 Method of producing a palatability enhancer that can add health value to foodstuffs |
09/19/2007 | EP1680426B1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
09/19/2007 | EP1565196B1 Preparing method of dendritic cell for cancer immunotherapy |
09/19/2007 | EP1453526B1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
09/19/2007 | EP1157094B1 Method for the purification, recovery, and sporulation of cysts and oocysts |
09/19/2007 | CN101039687A Folic acid producing bifidobacterium bacterial strains, formulations and use thereof |
09/19/2007 | CN101039686A Immune stimulatory infant nutrition |
09/19/2007 | CN101039685A Agent for preventing or suppressing hepatopathy and functional food for preventing or suppressing hepatopathy |
09/19/2007 | CN101039684A Methods to enhance hemodynamic stability using oxygen carrying compositions |
09/19/2007 | CN101037670A Effecter cell for preventing and curing CEA positive tumor and preparation method and application thereof |
09/19/2007 | CN101037463A Method for preparing high-purity hyodeoxycholic acid by pig bile |